ABCL AbCellera Biologics Inc.

Fundamentals / CIK 0001703057 / USD

AbCellera Biologics Inc. reported $67.86M in revenue and a net loss of $148.3M for the trailing twelve months ended September 30, 2026 (up 18.8% year over year), with a -298.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ABCL in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$495.6M$247.8M$0-$193.5MFY 2019 Revenue: $11.61MFY 2019 Net Income: -$2.21M2019FY 2020 Revenue: $233.2MFY 2020 Net Income: $118.9M2020FY 2021 Revenue: $375.2MFY 2021 Net Income: $153.5M2021FY 2022 Revenue: $485.4MFY 2022 Net Income: $158.5M2022FY 2023 Revenue: $38.02MFY 2023 Net Income: -$146.4M2023FY 2024 Revenue: $28.83MFY 2024 Net Income: -$162.9M2024FY 2025 Revenue: $75.13MFY 2025 Net Income: -$146.4M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $75.13M $28.83M $38.02M $485.4M $375.2M $233.2M $11.61M
Research & Development $186.8M $167.3M $175.7M $107.9M $62.06M $29.39M $10.11M
Selling, General & Admin -- $98.27M $89.36M $66.75M $48.76M $15.75M $4.01M
Total Operating Expenses $292.2M $343.6M $275.2M $268.9M $170.8M $77.12M $15.73M
Operating Income -$217.1M -$314.8M -$237.2M $216.5M $204.4M $156.0M -$4.12M
EBITDA -$195.0M -$287.9M -$212.8M $244.4M $218.9M $160.9M -$2.51M
Interest Income $28.33M $38.47M $42.25M $16.08M $3.33M $293K $155K
Income Before Tax -$177.6M -$200.4M -$174.0M $239.1M $219.1M $157.8M -$2.21M
Income Tax Expense -$31.18M -$37.54M -$27.63M $80.58M $65.69M $38.91M --
Net Income -$146.4M -$162.9M -$146.4M $158.5M $153.5M $118.9M -$2.21M
Basic EPS -$0.49 -$0.55 -$0.51 $0.56 $0.56 $0.53 -$0.01
Diluted EPS -$0.49 -$0.55 -$0.51 $0.50 $0.48 $0.45 -$0.01
Basic Shares Outstanding 298.7M 294.3M 289.2M 285.1M 275.8M 159.2M 151.3M
Diluted Shares Outstanding 298.7M 294.3M 289.2M 314.8M 318.3M 263.1M 151.3M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $10.64M $4.05M $8.31M $44.85M $8.96M $17.08M $4.24M $5.05M
Research & Development $43.53M $45.99M $46.66M $50.09M $55.03M $39.21M $42.50M $46.08M
Selling, General & Admin $13.61M $13.85M $12.33M -- $24.96M $21.99M $19.07M $31.94M
Total Operating Expenses $63.95M $66.83M $65.83M $73.44M $85.23M $66.67M $66.89M $77.81M
Operating Income -$53.31M -$62.78M -$57.52M -$28.58M -$76.28M -$49.59M -$62.66M -$72.75M
EBITDA -$46.51M -$55.79M -$50.68M -$22.49M -$71.03M -$44.12M -$57.33M -$124.2M
Interest Income -- -- $3.64M $5.92M $6.76M $7.59M $5.52M $8.67M
Income Before Tax -$42.81M -$58.97M -$49.54M -$19.50M -$68.77M -$36.34M -$52.98M -$46.83M
Income Tax Expense -$2.05M -$3.54M -$6.37M -$10.55M -$11.65M -$1.62M -$7.36M -$12.62M
Net Income -$40.76M -$55.43M -$43.16M -$8.95M -$57.12M -$34.73M -$45.62M -$34.21M
Basic EPS -$0.13 -$0.18 -$0.14 -- -$0.19 -$0.12 -$0.15 --
Diluted EPS -$0.13 -$0.18 -$0.14 -- -$0.19 -$0.12 -$0.15 --
Basic Shares Outstanding 318.1M 305.6M 303.1M -- 298.9M 298.5M 297.7M --
Diluted Shares Outstanding 318.1M 305.6M 303.1M -- 298.9M 298.5M 297.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $128.5M $156.3M $133.3M $386.5M $476.1M $594.1M
Cash & Short-Term Investments $533.8M $625.6M $760.6M $386.5M $476.1M $594.1M
Accounts Receivable, Net $39.41M $31.98M $0 -- -- $903K
Inventory $6.34M $0 -- -- -- --
Other Current Assets $111.1M $67.14M $55.81M $75.41M $21.25M $5.97M
Total Current Assets $728.2M $751.4M $872.0M $1.03B $929.8M $813.3M
Property, Plant & Equipment, Net -- -- -- $217.3M $111.6M $17.92M
Goodwill $47.81M $47.81M $47.81M $47.81M $47.81M $31.50M
Intangible Assets $38.38M $42.11M $120.4M $131.5M $148.4M $115.2M
Other Non-Current Assets $51.95M $96.54M $94.24M $46.33M $30.64M $8.39M
Total Non-Current Assets $628.7M $609.2M $616.1M $515.4M $388.8M $192.2M
Total Assets $1.36B $1.36B $1.49B $1.54B $1.32B $1.01B
Short-Term Debt -- -- -- -- -- $190K
Deferred Revenue (Current) $13.53M $13.52M $18.96M $21.61M $7.54M $6.59M
Total Current Liabilities $64.31M $76.61M $119.0M $118.3M $120.7M $103.5M
Deferred Revenue (Non-Current) $3.50M $5.70M $8.20M $19.52M $27.41M --
Other Non-Current Liabilities $10.38M $7.17M $5.91M $3.09M $1.73M $6.62M
Total Non-Current Liabilities $325.7M $227.9M $216.8M $189.3M $172.2M $71.54M
Total Liabilities $390.0M $304.5M $335.8M $307.6M $292.8M $175.0M
Total Debt (incl. Leases) $143.2M $65.36M $77.38M $82.26M $40.06M $4.58M
Common Stock $802.3M $777.2M $753.2M $734.4M $722.4M $710.4M
Retained Earnings -$29.48M $116.9M $279.8M $426.2M $267.7M $114.2M
Accumulated Other Comp. Income -$4.23M -$4.38M -$1.72M -$1.39M $280K --
Total Stockholders' Equity $966.9M $1.06B $1.15B $1.23B $1.03B $830.5M
Total Equity $966.9M $1.06B $1.15B $1.23B $1.03B $830.5M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $163.8M $120.1M $77.06M $128.5M $83.16M $92.44M $159.3M $156.3M
Cash & Short-Term Investments $764.4M $540.1M $504.7M $533.8M $495.7M $553.1M $605.3M $625.6M
Accounts Receivable, Net $38.29M $38.42M $39.16M $39.41M $71.25M $70.00M $63.61M $31.98M
Inventory $7.57M $7.58M $7.86M $6.34M -- -- -- $0
Other Current Assets $68.77M $95.53M $98.10M $111.1M $133.0M $116.8M $94.71M $67.14M
Total Current Assets $876.2M $679.2M $664.6M $728.2M $695.1M $742.1M $765.0M $751.4M
Goodwill $47.81M $47.81M $47.81M $47.81M $47.81M $47.81M $47.81M $47.81M
Intangible Assets $38.39M $36.53M $37.46M $38.38M $39.32M $40.26M $41.19M $42.11M
Other Non-Current Assets $63.62M $62.10M $69.14M $51.95M $53.07M $57.45M $61.56M $96.54M
Total Non-Current Assets $623.7M $628.3M $642.5M $628.7M $660.9M $659.9M $579.2M $609.2M
Total Assets $1.50B $1.31B $1.31B $1.36B $1.36B $1.40B $1.34B $1.36B
Deferred Revenue (Current) $35.04M $20.70M $7.74M $13.53M $15.69M $16.95M $18.79M $13.52M
Total Current Liabilities $70.47M $53.19M $47.29M $64.31M $68.80M $67.02M $75.40M $76.61M
Deferred Revenue (Non-Current) $48.05M $40.45M -- $3.50M $5.85M $11.63M $13.75M $5.70M
Other Non-Current Liabilities $10.44M $9.71M $11.32M $10.38M $1.39M $1.56M $1.62M $7.17M
Total Non-Current Liabilities $366.9M $358.4M $321.7M $325.7M $323.1M $328.0M $245.8M $227.9M
Total Liabilities $437.4M $411.6M $369.0M $390.0M $392.0M $395.0M $321.2M $304.5M
Total Debt (incl. Leases) $133.8M $135.6M $140.2M $143.2M $142.2M $142.1M $67.85M $65.36M
Common Stock $996.2M $821.2M $816.5M $802.3M $794.5M $791.7M $790.1M $777.2M
Retained Earnings -$168.8M -$128.1M -$72.65M -$29.48M -$20.54M $36.58M $71.31M $116.9M
Accumulated Other Comp. Income -$3.42M -$3.15M -$2.42M -$4.23M -$2.70M -$2.66M -$7.00M -$4.38M
Total Stockholders' Equity $1.06B $896.0M $938.1M $966.9M $964.0M $1.01B $1.02B $1.06B
Total Equity $1.06B $896.0M $938.1M $966.9M $964.0M $1.01B $1.02B $1.06B

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$146.4M -$162.9M -$146.4M $158.5M $153.5M $118.9M -$2.21M
Depreciation & Amortization $22.14M $26.84M $24.39M $27.84M $14.45M $4.84M $1.60M
Stock-Based Compensation $55.79M $67.58M $64.18M $49.48M $30.65M $8.40M $890K
Change in Receivables -$55.62M -$75.12M -$45.93M -$22.71M -$37.39M -$5.47M -$1.80M
Operating Cash Flow -$131.3M -$108.6M -$43.88M $277.4M $244.6M $22.69M $2.69M
Capital Expenditure -$42.77M -$78.40M -$76.95M -$70.66M -$58.45M -$9.67M -$4.00M
Free Cash Flow -$174.1M -$187.0M -$120.8M $206.7M $186.1M $13.02M -$1.30M
Acquisitions, Net -- -- $0 $0 -$11.46M -$87.64M --
Purchases of Investments -$436.0M -$765.1M -$1.02B -$764.0M -$274.7M -- --
Investing Cash Flow $87.75M $121.4M -$221.1M -$352.6M -$332.2M -$119.8M -$5.78M
Common Stock Issued -- -- -- -- -- $522.8M --
Financing Cash Flow $14.08M $12.77M $10.36M -$1.63M -$3.89M $683.7M $195K
Net Change in Cash -$28.37M $23.00M -$254.0M -$86.49M -$92.97M $586.6M -$2.89M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$40.76M -$55.43M -$43.16M -$8.95M -$57.12M -$34.73M -$45.62M -$34.21M
Depreciation & Amortization $6.81M $6.99M $6.84M $6.09M $5.25M $5.47M $5.33M -$51.45M
Stock-Based Compensation $11.67M $12.29M $12.01M $12.90M $13.89M $14.21M $14.79M $15.23M
Change in Receivables -- -- $13.10M -$39.67M -$3.43M -$11.39M -$1.13M -$20.86M
Operating Cash Flow $26.91M $25.92M -$33.52M -$34.74M -$52.59M -$32.40M -$11.55M -$8.00M
Capital Expenditure -$1.61M -$2.13M -$3.83M -$9.84M -$8.93M -$13.37M -$10.64M -$15.63M
Free Cash Flow $25.30M $23.79M -$37.35M -$44.59M -$61.52M -$45.77M -$22.19M -$23.63M
Purchases of Investments -$316.7M -$141.9M -$166.3M -$111.3M -$33.16M -$126.6M -$165.0M -$152.8M
Investing Cash Flow -$183.4M $11.34M -$25.08M $75.14M $36.49M -$31.81M $7.93M $35.70M
Financing Cash Flow $200.6M $6.39M $7.19M $4.12M $7.37M -$3.38M $5.97M $4.14M
Net Change in Cash $43.73M $43.23M -$51.45M $44.80M -$9.28M -$66.83M $2.94M $29.68M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -289.0% -1091.7% -623.8% 44.6% 54.5% 66.9% -35.5%
Net Profit Margin -194.9% -564.8% -385.0% 32.7% 40.9% 51.0% -19.0%
Return on Equity (ROE) -15.1% -15.4% -12.7% 12.9% 15.0% 14.3% --
Return on Assets (ROA) -10.8% -12.0% -9.8% 10.3% 11.6% 11.8% --
Current Ratio 11.32x 9.81x 7.33x 8.67x 7.70x 7.86x --
Quick Ratio 11.23x 9.81x 6.39x 3.27x 3.95x 5.75x --
Debt to Equity 0.15x 0.06x 0.07x 0.07x 0.04x 0.01x --
Revenue Growth (YoY) +160.6% -24.2% -92.2% +29.4% +60.9% +1907.9% --
Operating Income Growth (YoY) -- -- -209.6% +5.9% +31.0% -- --
Net Income Growth (YoY) -- -- -192.4% +3.3% +29.1% -- --
EPS Growth (YoY) -- -- -191.1% 0.0% +5.7% -- --
Operating Cash Flow Growth (YoY) -- -- -115.8% +13.4% +977.9% +742.2% --
Free Cash Flow Growth (YoY) -- -- -158.5% +11.1% +1329.9% -- --
5Y Revenue / Share Growth -82.8% +27.7% -- -- -- -- --
5Y Net Income / Share Growth -165.6% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -298.0% -340.3% -267.6% -289.0% -739.7% -847.6% -1395.3% -1091.6%
Net Profit Margin -218.5% -248.8% -181.7% -194.9% -486.0% -503.9% -726.2% -564.8%
Return on Equity (ROE) -14.0% -18.4% -15.3% -15.1% -17.8% -16.5% -16.4% -15.4%
Return on Assets (ROA) -9.9% -12.6% -11.0% -10.8% -12.7% -11.8% -12.5% -12.0%
Current Ratio 12.43x 12.77x 14.05x 11.32x 10.10x 11.07x 10.15x 9.81x
Quick Ratio 12.33x 12.63x 13.89x 11.23x 8.24x 9.30x 8.87x 9.81x
Debt to Equity 0.13x 0.15x 0.15x 0.15x 0.15x 0.14x 0.07x 0.06x
Revenue Growth (YoY) +18.8% -76.3% +96.3% +788.2% +37.6% +133.3% -57.5% -45.0%
Source: SEC EDGAR CompanyFacts (CIK 0001703057) · from December 31, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:18 UTC · Open in terminal